The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
MPN Hub
Claim This Podcastby Scientific Education Support
3.0(2 reviews)
31 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇬🇧
37
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality27
Social0
YouTube86
Engagement30
Podcast Overview
The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
6/30/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
37
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality27
Social0
YouTube86
Engagement30
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
23 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 100 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for MPN Hub
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 23, 2026
Symposium | Advanced systemic mastocytosis: Clinical challenges and unmet needs
<p>At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. During the symposium, Andreas Reiter, University Hospital Mannheim, Mannheim, DE, delivered a presentation on clinical challenges and unmet needs in advanced systemic mastocytosis (AdvSM). </p><p> </p><p>In this presentation, Reiter discusses how genetic complexity underpins disease heterogeneity and clinical presentation in AdvSM, how variable disease presentation can lead to diagnostic delays, and that treatment outcomes highlight variability across AdvSM subtypes. He explores the limitations of conventional disease burden assessment, the variable symptom burden impacts on quality of life across systemic mastocytosis (SM) subtypes, and how disease heterogeneity can lead to complexity in AdvSM management. In addition, he discusses the variability in morphology and genetics in SM with an associated hematologic neoplasm, and illustrates potential challenges in clinical practice using a patient case study. </p><br><p>This educational resource is independently supported by Blueprint medicines. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
July 22, 2026
Symposium | Disease biology and molecular architecture in advanced systemic mastocytosis
<p>At the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the MPN Hub held a symposium, titled Advanced systemic mastocytosis: Redefining the disease, rethinking patient outcomes. During the symposium, Deepti H Radia, Guy's and St Thomas' NHS Foundation Trust, London, UK, delivered a presentation on disease biology and molecular architecture in advanced systemic mastocytosis (AdvSM). </p><p> </p><p>In this presentation, Radia discusses the classification and biology of AdvSM, covering mast cell disease biology, the clinical and biological spectrum of AdvSM, KIT as a central molecular driver of AdvSM, additional somatic mutations, clonal architecture and disease evolution, and the mechanisms of disease progression and organ damage. </p><br><p>This educational resource is independently supported by Blueprint medicines. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence. </p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
July 16, 2026
Symposium | Future perspectives for cytopenic MF: Panel discussion and Q&A
<p>At the European School of Haematology (ESH) 11th Translational Research Conference: Myeloproliferative Neoplasms, Apr 24–26, 2026, Estoril, PT, the MPN Hub held a symposium, titled Patient-centered approaches in myelofibrosis: Tailoring treatment for anemia and thrombocytopenia. During the symposium, MPN Hub Steering Committee Chair Jean-Jacques Kiladjian, Université Paris Cité - Hôpital Saint-Louis, Paris, FR, and Steering Committee members Steffen Koschmieder, Uniklinik RWTH Aachen, DE, and Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discussed future perspectives for cytopenic myelofibrosis (MF) during a panel discussion and Q&A session. </p><br><p>In this presentation, Kiladjian, Koschmieder, and Harrison discuss practical approaches to the management of cytopenias in myelofibrosis, including treatment selection, management of treatment-emergent anemia, supportive care strategies, and future directions for individualized and combination therapies. </p><br><p>This educational resource is independently supported by GSK. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
31 total episodes available
Deep-dive analytics for MPN Hub
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is MPN Hub?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.